Nanotechnology, in the addition to treating different cancers, has been effective for the treatment of certain blood maladies and diseases. Blood-borne diseases work to infiltrate the blood stream and fester or attach themselves to cells causing infections and negative conditions. Nanotechnologies are being developed to counteract the infection and corruption process of the blood through a filtration and cleaning procedure. Nanotechnologies can be used to counteract the blood infection process by attaching to the infecting cells and microbes and removing them from the blood stream. The specific nanotechnology compounds used in the process are magnetic nanoparticles that are capable of separating the unhealthy blood cells from the healthy ones. To learn more about how blood purification can be performed with nanotechnology visit the website of a clinical nanotechnology company. You can get updates about research into nanotechnology and blood cells as well as explore the most recent nanotechnology developments.
To treat blood conditions with nanotechnologies, doctors create a circuit for the blood-flow similar to that in a normal dialysis machine, where it is treated outside of the body before being recirculated. Traditional dialysis treatments are unable to filter out pathogens specifically, instead they rely on a porous membrane to trap or remove particles of a certain size. While this can effectively purify the blood of toxins, it can often miss cells of a larger size and involves having to remove non-infected or toxic blood. Nanotechnology for blood therapy instead provides an opportunity to directly target the malign cells directly, removing them out of the body.
With a nanotech based blood purification system doctors still remove blood for treatment prior to re-circulation. But instead of using a membrane system to filter out size-specific substances and cells, doctors are able to use magnetic nanoparticles that directly target and bind to the harmful disease cells. The magnetic particles are a particle of metal at a size in the nanoscale that can be manipulated using a magnetic gradient. The particles are equipped with a bonding agent applied as a coating that allows them to be used as an adhesive to bind to the malign cells. When the nanoparticles have formed bonds with the pathogens a medical team applies a magnetic field or gradient that separates the combined nanoparticles and malign pathogens from the blood.
To learn more about how researchers are learning to treat blood diseases with nanotechnology you can follow a nanotechnology company’s website for updates and technology explanations.